Evidence map›Paper›PMID 42845491›Full record

ArticlebioRxiv : the preprint server for biology2026

Glucose repression of

Ang Li, Michael Springer

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ang LiDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-3933-588X
Michael SpringerDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-3970-6380

Funding

A novel and simple mechanism by which cells can sense enzymatic fluxR01GM148497 · NIGMS · HARVARD MEDICAL SCHOOL · PI Michael Springer · 2023 to 2026
$1.4M
NIGMS NIH HHS R01 GM148497
6 · The paper itself

Abstract

Glucose is the preferred carbon source for budding yeast. Glucose sensing is achieved through multiple pathways, and the regulation of glucose-responsive genes has been reported to depend on both glucose concentration and glucose flux. However, the extent to which either of these mechanisms is used, and how cells sense glucose metabolic flux and couple it to transcriptional repression, remains unclear. Using tunable control of hexose transporters and hexokinases together with an optimized intracellular glucose sensor, we decoupled glucose uptake, phosphorylation, and intracellular glucose levels. We found that regulation of a Mig1-dependent reporter gene correlates with glucose flux rather than glucose concentration. Deletion of all known plasma membrane glucose sensors or replacement of yeast hexokinase with a bacterial glucokinase did not disrupt flux-correlated repression. Systematic mutational analysis of glucose signaling pathways showed that this Mig1-dependent response is mediated by the Snf1/AMPK pathway, but only at low glucose concentrations. At high glucose concentrations, Mig1 activity is controlled by an unknown, non-canonical mechanism. While consistent with much of the extensive literature on glucose regulation in

Identifiers

PMID42845491
PMCPMC13640663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.